WuXi Biologics (Cayman) Inc.
2269
Clasificación en acciones
#991
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Precio por acción
$5.74
Capitalización bursátil
$23.64B
Cambio (1 día)
-8.79%
Cambio (1 año)
24.58%
País
CN
Comercio WuXi Biologics (Cayman) Inc. (2269)
Categoría
Healthcare
Ratio P/B de WuXi Biologics (Cayman) Inc. (2269)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de WuXi Biologics (Cayman) Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de WuXi Biologics (Cayman) Inc. desde 2014 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2025 | 2.49 | 54.96% |
| 2024 | 1.61 | -40.03% |
| 2023 | 2.68 | -57.33% |
| 2022 | 6.29 | -38.77% |
| 2021 | 10.28 | -41.50% |
| 2020 | 17.56 | 91.24% |
| 2019 | 9.18 | 26.97% |
| 2018 | 7.23 | -26.16% |
| 2017 | 9.80 | -90.76% |
| 2016 | 106.02 | -42.27% |
| 2015 | 183.65 | 166.79% |
| 2014 | 68.84 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 6.251 | - |
US
|
|
| 13.2547 | - |
US
|
|
| 4.208 | - |
AU
|
|
| 6.1824 | - |
NL
|
|
| - | - |
CH
|
